There’s a testosterone crisis, the FDA says

Orion Rummler

LGBTQ+ Reporter

Published

Republish this story

Republish this story

The problem, the experts said, is that nobody has been listening to men.

For too long, hormone therapy has been inaccessible for cisgender men who need it — or so said clinicians, professors and a pharmaceutical CEO gathered this week by the Food and Drug Administration (FDA). Testosterone, a controlled substance, should be deregulated and patients should be able to access it at pharmacies without stigma, they said. Low testosterone in men is not just a cosmetic issue, they claimed — it’s an American health crisis.

Experts at Wednesday’s FDA panel presented a unified and mostly rosy view of testosterone, praising it as the answer to common ailments that follow men as they age: weight gain, loss of musc